Insight Molecular Diagnostics Inc. 8-K

What Happened
Insight Molecular Diagnostics Inc. (iMDx) filed a Form 8‑K on May 13, 2026 (Item 2.02) to announce its results of operations and financial condition for the three months ended March 31, 2026. The company issued a press release on May 13, 2026 reporting its quarterly financial results; that press release is furnished as Exhibit 99.1 to the 8‑K and is incorporated by reference.

Key Details

• Form 8‑K filed on May 13, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• The results cover the quarter ended March 31, 2026.
• Press release announcing the quarterly results is attached as Exhibit 99.1 to the filing.
• The filing also includes Inline XBRL interactive data (Exhibit 104).

Why It Matters
This 8‑K is the company’s official disclosure of its quarterly earnings and financial condition for Q1 2026. Retail investors should read the attached press release for the actual earnings, revenue, and other financial metrics, and monitor subsequent filings (such as the quarterly report on Form 10‑Q) for detailed, audited financial statements and management discussion. Quarterly results can affect the company’s stock performance and provide insight into trends in revenue, profitability, and operations.